UNITED STATES NEWS

10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions

Aug 28, 2023, 9:04 PM | Updated: Aug 29, 2023, 12:28 pm

WASHINGTON (AP) — President Joe Biden, struggling to convince Americans that he’s improved their lives as he runs for reelection, hailed his administration’s Tuesday announcement that several drugs would be targeted for Medicare’s first-ever price negotiations.

The drugs include the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications. The negotiation process was authorized under the Inflation Reduction Act, which Biden signed last year, capping decades of debate over whether the federal government should be allowed to haggle with pharmaceutical companies.

Any lower prices won’t take effect for three years, and the path forward could be further complicated by litigation from drugmakers and heavy criticism from Republicans.

But the effort is a centerpiece of Biden’s reelection pitch as the Democrat tries to show Americans he’s deserving of a second term because of the work he’s doing to lower costs while the country is struggling with inflation. The drug negotiations, like many of Biden’s biggest policy moves, will take time to play out, and his challenge is to persuade the public to be patient.

“For all of you out there, I get it, and millions of Americans get it,” Biden said at the White House. “I promise you. I’m going to have your back and I’ll never stop fighting for you on this issue.”

He noted that he got “no help from the other team” — meaning Republicans — when it came to lowering prescription costs.

The drugs on the list announced Tuesday accounted for $3.4 billion in out-of-pocket costs for Medicare patients last year.

The Medicare program paid more than $50 billion for the drugs between June 1, 2022, and May 31, according to the Centers for Medicare and Medicaid Services, or CMS.

That includes more than $16 billion on Eliquis, a total that does not count discounts or rebates that are already negotiated for the drug. The drug from Pfizer and Bristol-Myers Squibb treats blood clots in the legs and lungs and reduces the risk of stroke in people with an irregular heartbeat called atrial fibrillation.

The diabetes treatments Jardiance from Eli Lilly and Co. and Boehringer Ingelheim and Januvia from Merck made the list. It also included Amgen’s autoimmune disease treatment Enbrel and Entresto from Novartis, which is used to treat heart failure.

Other drugs on the list include AstraZeneca’s diabetes and heart failure treatment Farxiga and three drugs from Johnson & Johnson: the blood thinner Xarelto, the blood cancer treatment Imbruvica and it’s biggest seller, Stelara, an IV treatment for psoriasis and other inflammatory disorders.

The list also includes several versions of Novo Nordisk’s Fiasp, a fast-acting insulin taken around meals.

The announcement Tuesday is another significant step toward taming drug pricing under the Inflation Reduction Act, which was signed by Biden last year. The law also calls for a $2,000 annual cap on how much people with Medicare have to pay out of pocket for drugs starting in 2025.

In addition, the law already caps out-of-pocket costs for insulin at $35 a month for Medicare patients.

“We are here today with the firm belief that in the United States of America, no senior should have to choose between whether they fill their prescription or fill their fridge with food,” Vice President Kamala Harris said.

For drugs on the list released Tuesday, the government aims to negotiate the lowest maximum fair price. That could help some patients who have coverage but still face big bills like coinsurance payments when they get a prescription.

About 9% of Medicare beneficiaries age 65 and older said in 2021 that they did not fill a prescription or skipped a drug dose due to cost, according to research by the Commonwealth Fund, which studies health care issues.

Currently, pharmacy benefit managers that run Medicare prescription plans negotiate rebates off a drug’s price. Those rebates sometimes help reduce premiums customers pay for coverage. But they may not directly change what a patient spends at the pharmacy counter.

The new drug price negotiations aim “to basically make drugs more affordable while also still allowing for profits to be made,” said Gretchen Jacobson, who researches Medicare issues at Commonwealth.

The federal government will benefit most from any lowered drug prices, noted Larry Levitt, an executive vice president for health policy at KFF, another non-profit that studies health care. But he said that if Medicare spends less on prescription drugs, then premiums for everyone with its drug coverage also should fall.

Drug companies that refuse to be a part of the new negotiation process will be heavily taxed.

The pharmaceutical industry has been gearing up for months to fight these rules. The lobbying group Pharmaceutical Research and Manufacturers of America said Tuesday that the drug list announcement stemmed from “a rushed process focused on short-term political gain rather than what is best for patients.”

“Many of the medicines selected for price setting already have significant rebates and discounts due to the robust private market negotiation that occurs in the Part D program today,” PhRMA CEO Stephen J. Ubl said in a statement.

PhRMA representatives also have said pharmacy benefit managers can still restrict access to drugs with negotiated prices by moving the drugs to a tier of their formulary — a list of covered drugs — that would require higher out-of-pocket payments. Pharmacy benefit managers also could require patients to try other drugs first or seek approval before a prescription can be covered.

PhRMA and several drugmakers have filed lawsuits over the administration’s plan.

Republican lawmakers also have blasted the Biden administration, saying companies might pull back on introducing new drugs that could be subjected to future haggling. They’ve also questioned whether the government knows enough to suggest prices for drugs.

CMS plans to meet this fall with drugmakers that have a drug on its list, and government officials say they also plan to hold patient-focused listening sessions. By February 2024, the government will make its first offer on a maximum fair price and then give drugmakers time to respond.

CMS aims to add 15 more drugs to its negotiation list for 2027 and another 15 for 2028. It then plans to add up to 20 more for each year after that.

___

Murphy reported from Indianapolis.

United States News

A "vote here" sign sits outside a Phoenix polling place in 2022....

Associated Press

Judge rules Arizona’s new voting laws requiring proof of citizenship aren’t discriminatory

An Arizona district judge has ruled state legislators didn't discriminate when passing new voting laws that require proof of citizenship.

1 hour ago

FILE - Phill Cady holds a sign during a "Take Our Border Back" rally on Feb. 3, 2024, in Quemado, T...

Associated Press

Russian disinformation is about immigration. The real aim is to undercut Ukraine aid

WASHINGTON (AP) — For Vladimir Putin, victory in Ukraine may run through Texas’ Rio Grande Valley. In recent weeks, Russian state media and online accounts tied to the Kremlin have spread and amplified misleading and incendiary content about U.S. immigration and border security. The campaign seems crafted to stoke outrage and polarization before the 2024 […]

2 hours ago

FILE - Defendant Kevin Monahan, left, listens to opening statements in his murder trial, Jan. 11, 2...

Associated Press

Man to be sentenced for murdering a woman who was mistakenly driven up his rural New York driveway

FORT EDWARD, N.Y. (AP) — A man who fatally shot a 20-year-old woman in an SUV that was mistakenly driven up his rural driveway in upstate New York is scheduled to be sentenced Friday. Kevin Monahan, 66, was convicted of second-degree murder in the death last April of Kaylin Gillis. Gillis was riding in a […]

8 hours ago

David and Stephanie Joiner pose by part of an artwork, called Greenwood Pond: Double Site, Sunday, ...

Associated Press

Artists outraged by removal of groundbreaking work along Des Moines pond

DES MOINES, Iowa (AP) — A Des Moines arts organization is preparing to rip out a groundbreaking artwork that lines a pond in a historic city park, surprising the New York artist who created the work decades ago and leading to an outpouring of opposition by other artists and local residents. The decision to remove […]

8 hours ago

Associated Press

Parts of the Sierra Nevada likely to get 10 feet of snow from powerful storm by weekend

RENO, Nev. (AP) — The most powerful Pacific storm of the season is forecast to bring up to 10 feet (3 meters) of snow into the Sierra Nevada by the weekend, forcing residents to take shelter and prompting Yosemite National Park and at least one Lake Tahoe ski resort to close. The storm began barreling […]

9 hours ago

FILE - Paramedic Peter Cichuniec attends his arraignment at the Adams County Justice Center in Brig...

Associated Press

Paramedic convictions in Elijah McClain’s death spur changes for patients in police custody

DENVER (AP) — Medical responders across the U.S. are rethinking how they treat people in police custody after a jury last December handed down a rare decision: It convicted two Colorado paramedics for their roles in the 2019 death of Elijah McClain following an overdose of a powerful sedative. As one of the paramedics faces […]

9 hours ago

Sponsored Articles

...

Fiesta Bowl Foundation

The 51st annual Vrbo Fiesta Bowl Parade is excitingly upon us

The 51st annual Vrbo Fiesta Bowl Parade presented by Lerner & Rowe is upon us! The attraction honors Arizona and the history of the game.

...

Collins Comfort Masters

Avoid a potential emergency and get your home’s heating and furnace safety checked

With the weather getting colder throughout the Valley, the best time to make sure your heating is all up to date is now. 

...

Day & Night Air Conditioning, Heating and Plumbing

Valley residents should be mindful of plumbing ahead of holidays

With Halloween in the rear-view and more holidays coming up, Day & Night recommends that Valley residents prepare accordingly.

10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions